The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma

被引:28
作者
Hartmann, Sylvia [1 ,2 ]
Pluetschow, Annette [3 ,4 ]
Mottok, Anja [5 ,6 ,7 ,8 ]
Bernd, Heinz-Wolfram [9 ]
Feller, Alfred C. [9 ]
Ott, German [10 ]
Cogliatti, Sergio [11 ]
Fend, Falko [12 ]
Quintanilla-Martinez, Leticia [12 ]
Stein, Harald [13 ]
Klapper, Wolfram [14 ]
Moeller, Peter [15 ]
Rosenwald, Andreas [5 ,6 ]
Engert, Andreas [3 ,4 ]
Hansmann, Martin-Leo [1 ,2 ,16 ]
Eichenauer, Dennis A. [3 ,4 ]
机构
[1] Goethe Univ, Senckenberg Inst Pathol, Frankfurt, Germany
[2] Goethe Univ, Reference & Consultat Ctr Lymph Node & Lymphoma P, Frankfurt, Germany
[3] Univ Cologne, Ctr Integrated Oncol Aachen Bonn Cologne Dusseldo, Dept Internal Med 1, Cologne, Germany
[4] Univ Hosp Cologne, German Hodgkin Study Grp, Cologne, Germany
[5] Univ Wurzburg, Inst Pathol, Wurzburg, Germany
[6] Comprehens Canc Ctr CCC Mainfranken, Wurzburg, Germany
[7] Ulm Univ, Inst Human Genet, Ulm, Germany
[8] Ulm Univ, Med Ctr, Ulm, Germany
[9] Hematopathol Lubeck, Lubeck, Germany
[10] Robert Bosch Krankenhaus & Dr Margarete Fischer B, Dept Clin Pathol, Stuttgart, Germany
[11] Kantonsspital St Gallen, Inst Pathol, St Gallen, Switzerland
[12] Eberhard Karls Univ Tubingen, Inst Pathol, Tubingen, Germany
[13] Berlin Reference Ctr Lymphoma & Hematopathol, Pathodiagnost Berlin, Berlin, Germany
[14] Univ Hosp Schleswig Holstein, Hematopathol Sect & Lymph Node Registry, Inst Pathol, Campus Kiel, Kiel, Germany
[15] Univ Hosp Ulm, Inst Pathol, Ulm, Germany
[16] Frankfurt Inst Adv Studies, Frankfurt, Germany
关键词
PROGNOSTIC IMPACT; TRANSFORMATION; DISEASE;
D O I
10.1002/ajh.25607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) can present with different histopathological growth patterns. The impact of these histopathological growth patterns on relapse characteristics is unknown. We therefore analyzed paired biopsies obtained at initial diagnosis and relapse from 33 NLPHL patients who had received first-line treatment within German Hodgkin Study Group (GHSG) trial protocols, and from a second cohort of 41 relapsed NLPHL patients who had been treated outside GHSG studies. Among the 33 GHSG patients, 21 patients presented with a typical growth pattern at initial diagnosis, whereas 12 patients had a variant histology. The histopathological growth patterns at initial diagnosis and at relapse were consistent in 67% of cases. A variant histology at initial diagnosis was associated with a shorter median time to lymphoma recurrence (2.8 vs 5.2 years; P = .0219). A similar tendency towards a shorter median time to lymphoma recurrence was observed for patients presenting with a variant histology at relapse, irrespective of the growth pattern at initial diagnosis. Results obtained from the 41 NLPHL patients who had been treated outside GHSG studies were comparable (median time to lymphoma recurrence for variant histology vs typical growth pattern at initial diagnosis: 1.5 vs 7.0 years). In conclusion, the histopathological growth pattern remains consistent at relapse in the majority of NLPHL cases, and has major impact on the time of relapse.
引用
收藏
页码:1208 / 1213
页数:6
相关论文
共 50 条
  • [21] Progress in understanding the biology of nodular lymphocyte-predominant Hodgkin lymphoma
    Straus, David J.
    HAEMATOLOGICA, 2021, 106 (10) : 2538 - 2538
  • [22] Nodular Lymphocyte Predominant Hodgkin Lymphoma Presenting With Unilateral Orbital Involvement
    Mettu, Pradeep
    Griffith, Megan
    Yohe, Sophia
    Harrison, Andrew R.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 33 (02) : E29 - E31
  • [23] High Familial Risk in Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Saarinen, Silva
    Pukkala, Eero
    Vahteristo, Pia
    Makinen, Markus J.
    Franssila, Kaarle
    Aaltonen, Lauri A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (07) : 938 - 943
  • [24] Primary Extranodal Nodular Lymphocyte Predominant Hodgkin Lymphoma Involving the Thyroid
    Williams, Todd P.
    Raess, Philipp W.
    Braziel, Rita
    Cascio, Michael J.
    HEAD & NECK PATHOLOGY, 2020, 14 (02) : 550 - 553
  • [25] How I treat nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Engert, Andreas
    BLOOD, 2020, 136 (26) : 2987 - 2993
  • [26] Individualized patient care in nodular lymphocyte-predominant Hodgkin lymphoma
    Borchmann, Sven
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2022, (01) : 717 - 722
  • [27] The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma
    Maeda, Lauren S.
    Advani, Ranjana H.
    CURRENT OPINION IN ONCOLOGY, 2009, 21 (05) : 397 - 400
  • [28] Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion
    Sidda, Adarsh
    Naleid, Nikolas Kristopher
    Manu, Gurusidda
    Graffeo, Vincent
    Jamil, Muhammad Omer
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2022, 10
  • [29] High-grade transformation in nodular lymphocyte predominant Hodgkin lymphoma
    Nayak, Sonali Susmita
    Parthiban, Sangeetha K.
    Paul, Peter
    Gujral, Sumeet
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2020, 63 (03) : 503 - +
  • [30] EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience
    Fei, Fei
    Kiruthiga, Kala Gnanasekaran
    Younes, Sheren
    Natkunam, Yasodha
    HUMAN PATHOLOGY, 2022, 129 : 32 - 39